Eighty females ( 20-65 years old ) undergoing thyroid surgery were prospectively recruited and randomized to either the TIVA ( effect-site target controlled infusion using propofol and remifentanil ) or DES ( desflurane inhalation with manual infusion of remifentanil ) groups .